Kane Biotech Statistics
Total Valuation
Kane Biotech has a market cap or net worth of 5.96 million. The enterprise value is 6.66 million.
| Market Cap | 5.96M |
| Enterprise Value | 6.66M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 166.23M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.80% |
| Shares Change (QoQ) | +20.30% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 90.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.40 |
| PB Ratio | -34.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.73 |
| EV / Sales | 5.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.19 |
Financial Position
The company has a current ratio of 1.20
| Current Ratio | 1.20 |
| Quick Ratio | 0.88 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.91 |
| Interest Coverage | -9.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -45.39% |
| Return on Invested Capital (ROIC) | -88.76% |
| Return on Capital Employed (ROCE) | -156.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.60 |
Taxes
| Income Tax | -960,697 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.56% in the last 52 weeks. The beta is 0.16, so Kane Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -63.56% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 72.70 |
| Average Volume (20 Days) | 393 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kane Biotech had revenue of 1.36 million and -2.44 million in losses. Loss per share was -0.02.
| Revenue | 1.36M |
| Gross Profit | 343,488 |
| Operating Income | -2.10M |
| Pretax Income | -2.44M |
| Net Income | -2.44M |
| EBITDA | -2.08M |
| EBIT | -2.10M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 1.18 million in cash and 1.90 million in debt, giving a net cash position of -719,498.
| Cash & Cash Equivalents | 1.18M |
| Total Debt | 1.90M |
| Net Cash | -719,498 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -172,296 |
| Book Value Per Share | -0.00 |
| Working Capital | 295,402 |
Cash Flow
In the last 12 months, operating cash flow was -2.08 million and capital expenditures -10,541, giving a free cash flow of -2.09 million.
| Operating Cash Flow | -2.08M |
| Capital Expenditures | -10,541 |
| Free Cash Flow | -2.09M |
| FCF Per Share | n/a |
Margins
Gross margin is 25.34%, with operating and profit margins of -154.85% and -179.77%.
| Gross Margin | 25.34% |
| Operating Margin | -154.85% |
| Pretax Margin | -180.02% |
| Profit Margin | -179.77% |
| EBITDA Margin | -153.75% |
| EBIT Margin | -154.85% |
| FCF Margin | n/a |
Dividends & Yields
Kane Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.80% |
| Shareholder Yield | n/a |
| Earnings Yield | -40.89% |
| FCF Yield | -35.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 13, 2017. It was a reverse split with a ratio of 0.2.
| Last Split Date | Mar 13, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
Kane Biotech has an Altman Z-Score of -12.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.79 |
| Piotroski F-Score | 3 |